Overview

A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
A randomized placebo controlled double-blind cross-over trial of Dalfampridine ER for effect on ambulatory activity in people with multiple sclerosis
Phase:
Phase 4
Details
Lead Sponsor:
Brown, Theodore R., M.D., MPH
Collaborator:
Acorda Therapeutics
Treatments:
4-Aminopyridine